ReviewWorld journal of diabetes2019

Development of therapeutic options on type 2 diabetes in years: Glucagon-like peptide-1 receptor agonist's role intreatment; from the past to future.

Hakan Dogruel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.